Trials / Conditions / Minimally Invasive Lung Adenocarcinoma
Minimally Invasive Lung Adenocarcinoma
5 registered clinical trials studyying Minimally Invasive Lung Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurre NCT03110978 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small NCT01386385 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage I NCT00334815 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non- NCT00126581 | National Cancer Institute (NCI) | Phase 2 |